Skip to content
Dose Brief
Menu

Edessa review

By Updated

Edessa publishes GLP-1 starting offers, but its longer-plan payments and conditional weight-loss refund require closer review.

Brief Score70/100Grade CNo. 169 in our directory
Visit Edessa View the provider’s current plans and terms.
Semaglutide

Confirm dose-specific total

From $135 for the first semaglutide month is advertised; continuing dose, supply and full payment need a quote.

Full price details

Compounded semaglutide offered; complete current dose-specific quote unknown; first-month offer from $135; earlier listing: $179/mo month-to-month injectable (compounded)

Tirzepatide

Confirm dose-specific total

Advertised $239 monthly; $219/$209 equivalents require three/six months. Full longer-plan payments need confirmation.

Full price details

Compounded tirzepatide offered; complete current commitment and dose-specific quote unknown; $239 monthly option advertised; earlier listing: $239/mo month-to-month (compounded)

Coverage
Advertises all 50 states plus DC, with medication and service exceptions
Brand-name
Generic FDA-approved medication fulfillment advertised; confirm the current named brand, price and eligibility.

Prices checked against Edessa's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Semaglutide advertises from $135; tirzepatide monthly $239 versus longer-plan equivalents. Complete quotes remain unconfirmed; the refund promise is conditional.

Edessa in depth

Separate monthly offers from longer commitments

Edessa’s homepage advertises semaglutide from $135 for the first month, with refills described as starting at the same amount. Its tirzepatide page lists $239 for the monthly option and lower equivalents for longer plans. Ask for your prescribed quantity, dose and complete charge before treating a starting figure as a continuing personal quote.

Tirzepatide equivalents are $219 on a three-month plan and $209 on a six-month plan. The reviewed page does not establish the full upfront payments. bmiMD, for example, lists both the term total and the monthly equivalent for each prepaid tier. Do not substitute those equivalents for a flexible monthly purchase. The billing guide helps compare the commitments once the actual payment schedule is confirmed.

Clinical review and pharmacy choice

The offers describe provider consultation, a personalized treatment plan, guidance and expedited shipping. A licensed clinician decides whether to prescribe. Edessa explicitly describes compounded medication, which is not FDA-approved. Its advertised weight-loss outcomes are not a guarantee of what an individual patient will experience. The site also advertises FDA-approved medication fulfillment, without establishing a current named brand or oral-treatment quote.

Terms name RedRock among pharmacy partners and say the final charge can vary with the medication and pharmacy chosen. Confirm your assigned pharmacy using the verification checklist. Nationwide availability is qualified by service and medication exceptions, so an advertised fifty-state footprint does not establish access to every prescription.

The money-back promise has conditions

The money-back policy requires demonstrating no weight loss after following the program for at least five months and retains a twenty-five-percent consultation deduction. That is different from an unconditional satisfaction refund. Ordinary prescription sales are described as final, and consultation fees are generally excluded from refunds.

Obtain the applicable program agreement before paying, including continuation prices, renewal authorization and cancellation timing. The reviewed public terms did not establish every plan’s refill deadline or complete prepaid refund calculation. Use the refund checklist, especially when considering a longer commitment based on the money-back banner.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

Edessa scored on our six Brief Score factors. See the methodology.

Price Stability64/100
Supply Reliability72/100
Transparency66/100
Access Breadth82/100
Clinical Oversight72/100
Track Record66/100

What we like

  • Publishes a monthly tirzepatide option
  • Includes provider guidance and shipping in advertised plans
  • Names pharmacy partners in its terms

The caveats

  • Longer-plan equivalents do not establish full upfront charges
  • Weight-loss refund retains a 25% consultation deduction
  • Final charges can vary with medication and pharmacy

The brief

Best for: Readers who can obtain a dose-specific quote and the full conditions behind the advertised money-back promise. Edessa publishes GLP-1 starting offers, but its longer-plan payments and conditional weight-loss refund require closer review.

Ranked #169 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Edessa.

Closest here

The providers scoring nearest Edessa — read each current assessment before choosing care.

Weighing Edessa against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Edessa, and every provider that outranks it is listed on the Edessa alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Edessa's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Edessa's site. Not medical advice; see our disclosure.

← Back to all rankings